Study of Concomitant Administration of the sIPV and DTaP or MMR

Clinical trial NCT06920069 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06920069
Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Polio Diphteria, Tetanus and Pertussis MMR Vaccine

Start date: 2025-05-15
Primary completion: 2030-07-15
Enrollment: 2640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.